Hamza Hashmi
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Hamza Hashmi
Jun 24, 2024, 22:06 |
Blog
Nausheen Ahmed: Approvals, toxicity and access updates on CART
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Jun 18, 2024, 15:42 |
Blog
Hamza Hashmi: Great kick-off to Best of ASCO updates with Binay Shah
Hamza Hashmi, Myeloma and Cellular Therapy Physician at Memorial Sloan Kettering Cancer, shared on X:…
Jun 9, 2024, 13:06 |
Insight
Urvi Shah: Annual myeloma team picnic!
Urvi Shah, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post on X:…
Jun 8, 2024, 15:44 |
Insight
Myeloma Paper of the Day, June 8th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Patients with extramedullary myeloma have…
May 21, 2024, 13:21 |
Insight
Rahul Banerjee: Two-for-one with new MMsm articles in press in Transplantation and Cellular Therapy Journal
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube